Showing 1 - 17 results of 17 for search 'Jing-Ping Liou', query time: 0.09s Refine Results
  1. 1
    Recent Update of HDAC Inhibitors in Lymphoma

    Recent Update of HDAC Inhibitors in Lymphoma by I-Chung Chen, Bidyadhar Sethy, Jing-Ping Liou

    Published 2020-09-01
    Get full text
    Article
  2. 2
    Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal

    Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal by Kunal Nepali, Ram Sharma, Sachin Sharma, Amandeep Thakur, Jing-Ping Liou

    Published 2022-09-01
    Get full text
    Article
  3. 3
    Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

    Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma by I-Ting Tsai, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang

    Published 2018-03-01
    Get full text
    Article
  4. 4
    Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.

    Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2. by Peifeng Hou, Ching-Ying Kuo, Chun-Ting Cheng, Jing-Ping Liou, David K Ann, Qiang Chen

    Published 2014-01-01
    Get full text
    Article
  5. 5
    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.

    MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27. by Hui Chen Pai, Sunil Kumar, Chien-Chang Shen, Jing Ping Liou, Shiow Lin Pan, Che Ming Teng

    Published 2015-01-01
    Get full text
    Article
  6. 6
    Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy

    Optimization and Development of Selective Histone Deacetylase Inhibitor (MPT0B291)-Loaded Albumin Nanoparticles for Anticancer Therapy by Athika Darumas Putri, Pai-Shan Chen, Yu-Lin Su, Jia-Pei Lin, Jing-Ping Liou, Chien-Ming Hsieh

    Published 2021-10-01
    Get full text
    Article
  7. 7
    A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway.

    A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway. by Nai-Jung Chiang, Ching-I Lin, Jing-Ping Liou, Ching-Chuan Kuo, Chi-Yen Chang, Li-Tzong Chen, Jang-Yang Chang

    Published 2013-01-01
    Get full text
    Article
  8. 8
    Synthesis and Biological Evaluation of 4-Aroyl-6,7,8-Trimethoxyquinolines as a Novel Class of Anticancer Agents

    Synthesis and Biological Evaluation of 4-Aroyl-6,7,8-Trimethoxyquinolines as a Novel Class of Anticancer Agents by Jing-Ping Liou, Jang-Yang Chang, Chih-Ying Nien, Cheng-Chih Hsieh, Chi-Yen Chang, Ching-Chuan Kuo, Hsueh-Yun Lee

    Published 2011-03-01
    Get full text
    Article
  9. 9
    Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model.

    Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model. by Jyh-Horng Wang, Kao-Shang Shih, Jing-Ping Liou, Yi-Wen Wu, Anita Shin-Yuan Chang, Kang-Li Wang, Ching-Lin Tsai, Chia-Ron Yang

    Published 2012-01-01
    Get full text
    Article
  10. 10
    Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo.

    Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo. by Han-Li Huang, Hsueh-Yun Lee, An-Chi Tsai, Chieh-Yu Peng, Mei-Jung Lai, Jing-Chi Wang, Shiow-Lin Pan, Che-Ming Teng, Jing-Ping Liou

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

    Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status by Min-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, Chao-Di Chang, Mei-Jung Lai, Yi-Ying Chen, Jing-Ping Liou, Che-Ming Teng, Shiow-Lin Pan

    Published 2019-05-01
    Get full text
    Article
  12. 12
    Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment

    Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment by Tung-Yun Wu, Michael Chen, I-Chung Chen, Yi-Jou Chen, Che-Yi Chen, Chang-Hung Wang, Jing-Jy Cheng, Kunal Nepali, Kuo-Hsiang Chuang, Jing-Ping Liou

    Published 2023-04-01
    Get full text
    Article
  13. 13
    MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma.

    MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. by Hsuan-Yu Peng, Yun-Ching Cheng, Yuan-Ming Hsu, Guan-Hsun Wu, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang, Shiow-Lian Catherine Jin, Shine-Gwo Shiah

    Published 2016-01-01
    Get full text
    Article
  14. 14
    Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer

    Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer by Sachin Sharma, Kavya Chandra, Aliva Naik, Anamika Sharma, Ram Sharma, Amandeep Thakur, Ajmer Singh Grewal, Ashwani K. Dhingra, Arnab Banerjee, Jing Ping Liou, Santosh Kumar Guru, Kunal Nepali

    Published 2023-12-01
    Get full text
    Article
  15. 15
    A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

    A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo by Yi-Wen Wu, Min-Wu Chao, Huang-Ju Tu, Liang-Chieh Chen, Kai-Cheng Hsu, Jing-Ping Liou, Chia-Ron Yang, Shih-Chung Yen, Wei-Chun HuangFu, Shiow-Lin Pan

    Published 2021-05-01
    Get full text
    Article
  16. 16
    Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells

    Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells by Wen-Bin Yang, An-Chih Wu, Tsung-I Hsu, Jing-Ping Liou, Wei-Lun Lo, Kwang-Yu Chang, Pin-Yuan Chen, Ushio Kikkawa, Shung-Tai Yang, Tzu-Jen Kao, Ruei-Ming Chen, Wen-Chang Chang, Chiung-Yuan Ko, Jian-Ying Chuang

    Published 2021-09-01
    Get full text
    Article
  17. 17
    A Potent Histone Deacetylase Inhibitor MPT0E028 Mitigates Emphysema Severity via Components of the Hippo Signaling Pathway in an Emphysematous Mouse Model

    A Potent Histone Deacetylase Inhibitor MPT0E028 Mitigates Emphysema Severity via Components of the Hippo Signaling Pathway in an Emphysematous Mouse Model by Lu-Yang Yeh, Yu-Ting Fang, Hong-Sheng Lee, Chia-Hao Liu, You-Yin Chen, Yu-Chun Lo, Vincent Laiman, Vincent Laiman, Jing-Ping Liou, Kian Fan Chung, Hsiao-Chi Chuang, Hsiao-Chi Chuang, Hsiao-Chi Chuang, Chien-Huang Lin

    Published 2022-05-01
    Get full text
    Article

Search Tools: